Showing results (31-40 of 365) with videos related to

Sort By:
Pageof 37
BMC Public Health|March 11, 2022
Household-specific physical activity levels and energy intakes according to the presence of metabolic syndrome in Korean young adults: Korean National Health and nutrition examination survey 2016-2018Young-Jun Lee, Yeon-Hee Park, Jung-Woo Lee, et al.
Targeted Oncology|September 28, 2021
An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast CancerYen-Shen Lu, Winnie Yeo, Yoon-Sim Yap, et al.
Leukemia & Lymphoma|April 23, 2004
Primary malignant lymphoma of the breast: clinicopathological study of nine casesYeon Hee Park, Sung Ho Kim, Seong-Jun Choi, et al.
BMC Cancer|October 16, 2015
Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II studySu Jin Lee, Sungmin Kim, Moonjin Kim, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 19, 2010
Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancerMyung Hee Chang, Jeeyun Lee, Joungho Han, et al.
Scientific Reports|September 9, 2016
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiencyHae Hyun Jung, Soo-Hyeon Lee, Ji-Yeon Kim, et al.
Breast Cancer Research : BCR|July 18, 2025
Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitorsWonseok Whi, Junghoon Shin, Ji-Yeon Kim, et al.
Cancer Research and Treatment|April 25, 2013
A case report of paraneoplastic pemphigus associated with esophageal squamous cell carcinomaJin Hyun Cho, Nam Jun Kim, Sung Min Ko, et al.
Archives of Gerontology and Geriatrics|June 14, 2022
Association of frailty with fall events in older adults: A 12-year longitudinal study in KoreaYoung-Sang Kim, Yao Yao, So-Won Lee, et al.
Oncology|November 13, 2010
Prognostic model to predict outcomes in non-small cell lung cancer patients with erlotinib as salvage treatmentSeung Tae Kim, Jeeyun Lee, Jong-Mu Sun, et al.
Pageof 37